NCT00216879

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

Long-term Treatment of Scalp Psoriasis With Calcipotriol Plus Betamethasone Dipropionate Gel

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 800 (planned)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the trial is to study the safety and efficacy of long term use of once daily applications, as needed, of calcipotriol plus betamethasone dipropionate gel, as compared to calcipotriol alone in the same gel. The primary response criteria will be the incidence of adverse drug reactions of any type, and the incidence of adverse events of concern associated with long-term corticosteroid use on the scalp.

Conditions

• Psoriasis of Scalp

Interventions

Type	Name	Description
DRUG	Calcipotriol plus betamethasone dipropionate gel (LEO 80185)

Timeline

• Start date: 2005-02-01
• Completion: 2006-07-01
• First posted: 2005-09-22
• Last updated: 2025-02-24

Locations

5 sites across 5 countries: Canada, Denmark, France, Germany, United Kingdom